000023826 000__ 01370cam\a2200457\i\4500
000023826 001__ 23826
000023826 003__ SzGeWIPO
000023826 005__ 20240708162201.0
000023826 008__ 990312s2007\\\\enk\\\\\r\\\\u000\0\hun\d
000023826 035__ $$a(wipo)(CD )99-0455
000023826 035__ $$a(OCoLC)1158920596
000023826 040__ $$aSzGeWIPO$$beng$$erda$$cSzGeWIPO$$dCaBNVSL
000023826 041__ $$aeng
000023826 043__ $$ae-uk---
000023826 050_4 $$aK1401.A15$$bJ675
000023826 08204 $$a346.048$$222
000023826 084__ $$aGB 137 2007 no 8
000023826 090__ $$c26065$$d26062
000023826 1001_ $$aEngland, Paul.
000023826 24510 $$aSaint Gobain :$$bpatron of pharmaceutical patentees?
000023826 264_1 $$aOxford [England] :$$bOxford University Press,$$cAugust 2007.
000023826 300__ $$a1 volume ([7] pages) ;$$c[28] cm.
000023826 336__ $$atext$$btxt$$2rdacontent
000023826 337__ $$aunmediated$$bn$$2rdamedia
000023826 338__ $$avolume$$bnc$$2rdacarrier
000023826 4901_ $$aJournal Of Intellectual Property Law & Practice,$$x1747-1532 ;$$v2007 Vol.2 No 8 pages 532-539
000023826 650_0 $$aIntellectual property.
000023826 650_0 $$aIntangible property.
000023826 650_0 $$aIntellectual property$$zUnited Kingdom.
000023826 650_0 $$aPatents$$zUnited Kingdom.
000023826 650_4 $$aPharmaceutical industry
000023826 650_4 $$aUnited Kingdom$$xCase Law
000023826 650_4 $$aPatents
000023826 650_4 $$aMusic industry$$xCase Law
000023826 651_0 $$aUnited Kingdom$$xCommerce$$xLaw and legislation.
000023826 830_0 $$aJournal Of Intellectual Property Law & Practice ;$$v2007 Vol.2 No 8 pages 532-539.
000023826 8564_ $$uhttp://jiplp.oxfordjournals.org/cgi/reprint/2/8/532.pdf
000023826 903__ $$v1$$aJournal of Intellectual Property law & Practice
000023826 904__ $$aJournal article
000023826 942__ $$cART
000023826 952__ $$w2007-08-16$$p2007-0573$$u37378$$bMAIN$$10$$kGB 137 2007 no 8$$v2007-08-16$$70$$cMAin Library$$yART
000023826 980__ $$aBIB
000023826 999__ $$c26065$$d26065